Ehrlich Christopher B 4
4 · eFFECTOR Therapeutics, Inc. · Filed Feb 21, 2024
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-02-19+2,000→ 2,000 totalExercise: $11.32Exp: 2034-02-18→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on February 19, 2024, subject to the Reporting Person's continued service with the Issuer through each vesting date.